Benzinga | Aug 16, 2021 07:12AM EDT

Curevac And GSK Announce Second-Generation MRNA COVID-19 Vaccine Candidate, Cv2Cov, Demonstrates Improved Immune Response And Protection In Preclinical Study

- Reuters